Advisors Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Advisors Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,692	Closed	-$810K	–	1780
2016 Q4	$810K	Sell	7,692 -1,214	-14%	-$127K	0.01%	958
2016 Q3	$984K	Sell	8,906 -6,223	-41%	-$824K	0.02%	868
2016 Q2	$2.2M	Sell	15,129 -1,760	-10%	-$250K	0.04%	616
2016 Q1	$2.42M	Sell	16,889 -1,528	-8%	-$217K	0.04%	586
2015 Q4	$2.85M	Sell	18,417 -1,967	-10%	-$287K	0.05%	547
2015 Q3	$2.91M	Buy	20,384 +3,589	+21%	+$502K	0.05%	523
2015 Q2	$2.41M	Buy	16,795 +4,265	+34%	+$608K	0.03%	609
2015 Q1	$1.77M	Buy	12,530 +6,756	+117%	+$1.04M	0.02%	711
2014 Q4	$856K	Buy	5,774 +3,768	+188%	+$554K	0.01%	902
2014 Q3	$309K	Buy	+2,006	New	+$302K	﹤0.01%	1175

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Advisors Asset Management's TARO Position: Q1 2017 in Review

Advisors Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 7,692 shares — an estimated $810K sold.

Advisors Asset Management first reported a position in TARO in Q3 2014 and held it in 10 quarters. The position peaked at $2.91M in Q3 2015. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

Advisors Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
Advisors Asset Management sold 7,692 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $810K.
Advisors Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 10 quarters.
Advisors Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.91M in Q3 2015.
139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Advisors Asset Management's 13F filing for Q1 2017, filed 2 May 2017.